TMEM41B: a pan-flavivirus and pan-coronavirus host factor with antiviral potential
TMEM41B: a pan-flavivirus and pan-coronavirus host factor with antiviral potential
批准号:
10587597
负责人:
Charles M Rice
金额:
$46.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-19 至 2027-07-31
关键词:
2019-nCoVAddressAmino AcidsArbovirus InfectionsAutophagocytosisBiological AssayCRISPR/Cas technologyCell LineageCellsCellular biologyCoronavirusCoronavirus InfectionsDisease OutbreaksDouble-Stranded RNADrug TargetingEnzymesEpidemicEventFamilyFlavivirusFlavivirus InfectionsGenesGenomeGoalsHealthHomeostasisHumanInfectionInnate Immune ResponseIntegral Membrane ProteinIntegration Host FactorsInterferonsInvestigationKnock-outKnowledgeLeadLipid MobilizationLipidsManuscriptsMembraneMembrane ProteinsModelingMolecularMorbidity - disease rateMusMutateNatural ImmunityOrganellesPathway interactionsPattern recognition receptorPharmaceutical PreparationsPhenotypePlayPolyproteinsPopulationProteinsPublishingRNARNA VirusesRNA replicationReportingResistanceRoleSeriesSignal TransductionSingle Nucleotide PolymorphismSiteStructureTestingTissuesTranslationsVacuoleViralViral GenomeVirusVirus DiseasesVirus ReplicationWorkarthropod-bornecombatconditional knockoutdruggable targetembryonic stem cellendoplasmic reticulum stressexperimental studygenetic approachgenome-widehuman pluripotent stem cellimmune activationineffective therapiesinsightlipid metabolismloss of functionmortalitymutantmutation screeningpandemic diseasepathogenpreventrecruitrespiratoryresponsestem cellssynergismtherapeutic targettranscriptome sequencingviral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Arthropod-borne flaviviruses and respiratory-transmitted coronaviruses have the potential to cause severe
epidemics and pandemics. One strategy to prepare for and respond to viral outbreaks is to develop drugs that
target host factors viruses require to complete their lifecycles. Through a series of CRISPR/Cas9 gene disruption
screens, we identified transmembrane protein 41B (TMEM41B) and the closely related vacuole membrane
protein 1 (VMP1) as critical pan-flavivirus and pan-coronavirus host factors. Both proteins are highly conserved
lipid scramblases with roles in autophagy. Our current model is that viruses from both the Flavivirdae and
Coronaviridae families hijack TMEM41B and VMP1 for their ability to remodel ER membranes and induce
membrane curvature to establish membrane-protected viral RNA replication organelles.
Our overall goal for this proposal is to understand how, on a mechanistic level, both proteins support
flavivirus and coronavirus infection. Our previous work indicates that TMEM41B is required at a post-entry step
at or prior to viral RNA replication. In Aim 1, we will interrogate early events of the virus lifecycle including primary
translation, polyprotein processing, and replication organelle formation in WT, TMEM41B and VMP1 knockout
(KO) cells to determine how far the flavivirus and coronavirus lifecycles progress in the absence of either protein.
We previously showed that lack of TMEM41B and VMP1, induces a heightened innate immune response
upon flavivirus infection. We hypothesize that both proteins are recruited to sites of viral RNA replication, and
that in their absence, RNA replication initiates and viral double stranded RNA (dsRNA) is produced. However,
without a proper replication organelle dsRNA is exposed and triggers an innate immune response. Alternatively,
given TMEM41B’s and VMP1’s lipid scramblase activity and function in lipid homeostasis, their absence may
induce ER stress, which triggers an unfolded protein response (UPR) that in synergy with dsRNA may cause a
heightened innate immune response. In Aim 2, we will test virus infection in double KO cells that lack either
protein in addition to genes that are essential for pathogen sensing, IFN signaling, and UPR activation. We will
further conduct RNAseq experiments to investigate lack of TMEM41B in stem cells and stem cell-derived
primary-like cells representing different tissue lineages in the absence and presence of viral replication.
Lastly, in Aim 3, will use a panel of phenotypic and mechanistic assays to characterize naturally occurring
SNPs in TMEM41B that we previously found to impact flavivirus replication, and several reported VMP1 loss-of-
function mutants. We will further take a deep mutational scanning approach to comprehensively characterize
TMEM41B and VMP1 and determine if any domains or amino acids are differentially required for their cellular
and proviral functions. This functional characterization will identify mutants that can be studied in detail in
mechanistic assays and may identify amino acids or interfaces in both proteins that can be targeted to prevent
virus infection with minimal disruption to cellular biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Employing viruses to unravel the functional significance of the m5C epitranscriptome
-
批准号:10638533
-
项目类别:
-
资助金额:$66.0万
-
财政年份:2023
-
负责人:Charles M Rice
-
依托单位:
Elucidating the mechanism by which ADAR1 prevents autoimmunity against self RNA
-
批准号:10667182
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2023
-
负责人:Charles M Rice
-
依托单位:
Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
-
批准号:10446423
-
项目类别:
-
资助金额:$63.76万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
-
批准号:10553697
-
项目类别:
-
资助金额:$62.82万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
-
批准号:10570297
-
项目类别:
-
资助金额:$61.93万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Scientific Core: BSL3 Virology and Animal Models
-
批准号:10327991
-
项目类别:
-
资助金额:$145.45万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Scientific Core: BSL3 Virology and Animal Models
-
批准号:10841239
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
-
批准号:10446620
-
项目类别:
-
资助金额:$68.19万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Virology Core
-
批准号:10513915
-
项目类别:
-
资助金额:$528.97万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
TMEM41B: a pan-flavivirus and pan-coronavirus host factor with antiviral potential
-
批准号:10707260
-
项目类别:
-
资助金额:$61.01万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
A renewable and genetically tractable human stem cell-derived multicellular platform for the study of fibrotic liver diseases
-
批准号:10576892
-
项目类别:
-
资助金额:$49.43万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
A renewable and genetically tractable human stem cell-derived multicellular platform for the study of fibrotic liver diseases
-
批准号:10360541
-
项目类别:
-
资助金额:$49.43万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
A renewable and genetically tractable human stem cell-derived multicellular platform for the study of fibrotic liver diseases
-
批准号:10211567
-
项目类别:
-
资助金额:$50.99万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
Defining therapeutic drug targets for SARS-CoV-2-specific and pan-coronavirus inhibition
-
批准号:10238377
-
项目类别:
-
资助金额:$48.35万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology
-
批准号:10555333
-
项目类别:
-
资助金额:$61.11万
-
财政年份:2020
-
负责人:Charles M Rice
-
依托单位:
Identification of host factors required by the tick-borne Powassan virus
-
批准号:10307148
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2020
-
负责人:Charles M Rice
-
依托单位:
Identification of host factors required by the tick-borne Powassan virus
-
批准号:10154884
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2020
-
负责人:Charles M Rice
-
依托单位:
In search of an HBV cure: novel model systems and targets
-
批准号:10400212
-
项目类别:
-
资助金额:$59.43万
-
财政年份:2019
-
负责人:Charles M Rice
-
依托单位:
HEP DART 2019: Frontiers in Drug Development for Hepatology
-
批准号:9914390
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2019
-
负责人:Charles M Rice
-
依托单位:
In search of an HBV cure: novel model systems and targets
-
批准号:10633080
-
项目类别:
-
资助金额:$59.43万
-
财政年份:2019
-
负责人:Charles M Rice
-
依托单位:
海外基金